Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

SLNSLN
11 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in Silence Therapeutics PLC Sponsored ADR

Qube Research & Technologies Ltd holds 163,945 shares of SLN (Silence Therapeutics PLC Sponsored ADR), worth $1.8M as of 2026-Q2. The position was increased (+56.8% shares). SLN represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$1.8M

Current Shares

163,945

Total Value Change

+$1.8M

Total Shares Change

+163,767

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
163,945
+56.8%
$1.8M0.0%$10.98
37
2026-Q1
Increased
104,555
+199.1%
$551,0050.0%$5.66
39
2025-Q4
New
34,962
-
$212,5690.0%$6.15
32
2025-Q2
Exited
0
-100.0%
$00.0%$5.79
0
2025-Q1
Decreased
18,913
-65.5%
$53,3350.0%$3.44
0
2024-Q4
Increased
54,746
+185.2%
$376,6520.0%$6.91
38
2024-Q3
New
19,196
-
$348,9830.0%$18.25
33
2024-Q2
Exited
0
-100.0%
$00.0%$19.00
0
2024-Q1
Increased
3,942
+2114.6%
$85,1470.0%$21.60
35
2023-Q4
Unchanged
178
0.0%
$3,0920.0%$17.37
0
2023-Q3
New
178
-
$1,7500.0%$9.82
17

Other major holders of SLN: MILLENNIUM MANAGEMENT LLC, Janus Henderson Group Ltd., Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used